These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7938143)

  • 1. [Molecular modeling and computer-aided drug design 1992-3--an overview].
    Folkers G
    Pharmazie; 1994 Aug; 49(8):551-61. PubMed ID: 7938143
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in modeling of biomolecular interactions.
    Cai CZ; Li ZR; Wang WL; Chen YZ
    Acta Pharmacol Sin; 2004 Jan; 25(1):1-8. PubMed ID: 14704115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].
    Hirono S
    Rinsho Byori; 2002 Jan; 50(1):45-51. PubMed ID: 11871136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational computer-aided design of ligands that bind endotoxin.
    Lawden KH; Pitts JM; Thomas JA; Lowe CR
    Prog Clin Biol Res; 1995; 392():443-52. PubMed ID: 8524951
    [No Abstract]   [Full Text] [Related]  

  • 7. Computer-based de novo design of drug-like molecules.
    Schneider G; Fechner U
    Nat Rev Drug Discov; 2005 Aug; 4(8):649-63. PubMed ID: 16056391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some thoughts on the "A" in computer-aided molecular design.
    Rarey M
    J Comput Aided Mol Des; 2012 Jan; 26(1):113-4. PubMed ID: 22160587
    [No Abstract]   [Full Text] [Related]  

  • 11. Computer-aided design of a PDZ domain to recognize new target sequences.
    Reina J; Lacroix E; Hobson SD; Fernandez-Ballester G; Rybin V; Schwab MS; Serrano L; Gonzalez C
    Nat Struct Biol; 2002 Aug; 9(8):621-7. PubMed ID: 12080331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C; Fischel O; Cohen E
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating molecular design resources within modern drug discovery research: the Roche experience.
    Stahl M; Guba W; Kansy M
    Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in QSAR-technology.
    Van de Waterbeemd H
    Drug Des Discov; 1993; 9(3-4):277-85. PubMed ID: 8400008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling.
    Feng J; Li Y; Shen B
    Peptides; 2004 Jul; 25(7):1123-31. PubMed ID: 15245871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening.
    Kubinyi H
    IDrugs; 2007 Dec; 10(12):869-73. PubMed ID: 18041683
    [No Abstract]   [Full Text] [Related]  

  • 17. Computer aids in drug design--highlights.
    Ghoshal N; Achari B; Ghoshal TK
    Pol J Pharmacol; 1996; 48(4):359-77. PubMed ID: 9112677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the use of open-source software applications in drug discovery.
    Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
    Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward in silico approaches for investigating the activity of nanoparticles in therapeutic development.
    Saliner AG; Poater A; Worth AP
    IDrugs; 2008 Oct; 11(10):728-32. PubMed ID: 18828072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).
    Kim SH; Pudzianowski AT; Leavitt KJ; Barbosa J; McDonnell PA; Metzler WJ; Rankin BM; Liu R; Vaccaro W; Pitts W
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1101-6. PubMed ID: 15686921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.